stay up to date on this topic
reviews and recommendations are unbiased and products are independently selected. postmedia may earn an affiliate commission from purchases made through links on this page.
epilepsy affects
roughly one per cent of the canadian population. the disorder, characterized by changes in brain activity known as a seizure, is often debilitating due to the sheer severity of symptoms.
when a person has a seizure, their brain short-circuits in a sense, and an uncontrolled burst of electrical activity causes changes in consciousness, movements, behaviour, or feelings. there are many different types of seizures, each one coming with its own set of signs, symptoms, and potentially life-threatening effects.
current therapies focus on medications, surgeries, medical devices, and specialized diets. for many with the disorder, one or a combination of the available therapies is enough to help control their seizures. still, for many others, like linda mcclure, no number of available treatments has been able to stop seizures from happening.
“i’ve had three temporal lobe lobectomies, where they had to remove a large portion of my right temporal lobe,” she said. “i’ve undergone additional depth probes and intracranial monitoring. i’ve done that twice.” she continues, “at one point, i was on four medications, and you can imagine the side effects of those. i mean, i was doped up.”
mcclure is not alone. according to
ucb canada, as many as 30 per cent of canadians living with epilepsy are living with uncontrolled seizures right now.
being in and out of the seizure unit multiple times and playing the guinea pig for the many seizure medications available is the norm for people like mcclure, who have uncontrolled and drug-resistant seizures. that could all change, though, with the introduction of a new drug called xcopri, also known as cenobamate.